Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Cetuximab in Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)
- Status
- UNKNOWN
- Phase
- PHASE2
Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
- Status
- UNKNOWN
- Phase
- PHASE2
QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2